Fluidigm Corp. (FLDM)

[Hole shot King]

The FDA recently approved 5-minute testing for COVID-19 detection from Abbott. How do these systems compare?

One of the big advantages of microfluidics technology is the capacity of throughput. The IFC structure can process up to 192 samples at once. Combined with a 2-hour run-time, it is can analyze thousands of samples in a day. In contrast to the Abbott point-of-care test, the microfluidics workflows are high-throughput and high-capacity. A direct comparison of the two platforms demonstrates that in a 4-hour span, the Biomark™ HD system can test 192 samples where a point-of-care test, such as the Abbott system, can process 48 samples.

$FLDM Q&A

https://www.fluidigm.com/singlearticles/covid-19-microfluidics-q-and-a?utm_source=LinkedIn&;